• Skip to primary navigation
  • Skip to main content
Kinderhook Industries

Kinderhook Industries

  • Investment Philosophy
  • Team
  • Our Portfolio
  • Portfolio News
  • LP Portal

Kinderhook Recapitalizes Longs and PharMedQuest to Create Leading Covered Entity Pharmacy Services Provider

Kinderhook Recapitalizes Longs and PharMedQuest to Create Leading Covered Entity Pharmacy Services Provider

December 4, 2019

New York, NY – Kinderhook Industries, LLC (“Kinderhook”) announced today its majority recapitalization of Long’s Drugs Inc. (“Longs”) and PharMedQuest Pharmacy Services, Inc. (“PharMedQuest” and, collectively, the “Company”). The Company provides on-site and central fill pharmacy services to healthcare facilities that focus on indigent and underserved populations, including Federally Qualified Health Centers (“FQHCs”), Ryan White Clinics and STD Clinics (collectively, “Covered Entities”). The transactions represent Kinderhook’s 12th Healthcare Services platform investment and its 43rd and 44th Healthcare Services acquisitions. Financial terms of the transactions were not disclosed.

Headquartered in Columbia, South Carolina, Longs provides comprehensive pharmacy services and distributes specialty pharmaceuticals across the United States. Longs offers tailored pharmacy solutions for Ryan White Clinics, Federally Qualified Health Centers, and STD Clinics. Longs owns and operates over 30 pharmacies in the Southeast under the Avita and Longs brands. Headquartered in Brea, California, PharMedQuest provides integrated on-site pharmacy management solutions to Federally Qualified Health Centers. PharMedQuest owns and operates 28 pharmacies across California.

The combination of Longs and PharMedQuest unites two of the leading on-site pharmacy management services providers for Covered Entities, boasting a national presence stretching coast to coast. Executives from the Longs management team will join PharMedQuest in facilitating the integration of the companies and continued growth of Covered Entity pharmacy services.

“This is a very exciting opportunity, as joining these two mission-driven companies together will accelerate the significant growth that each company has experienced over the past several years” said Lorrie Carr, CEO of the Company. “We will bring the best of both companies together and deliver the highest quality care and services for our patients and Covered Entity clients.”

“This is a merger of two highly compatible, innovative and industry leading pharmacies,” said Christi Epps, former CEO of Longs. “We hold similar values and philosophies on doing business; providing quality customer service to our clients and patients with an emphasis on honesty and integrity.”

Chris Michalik, Managing Director of Kinderhook Industries, stated, “We are thrilled to combine these leading brands with established histories of providing high quality pharmacy solutions to thousands of patients. We look forward to sharing best operating practices between the companies as we continue to build the leading integrated pharmacy services provider for Covered Entities.”

Kirkland & Ellis LLP served as legal counsel to Kinderhook. Financing for the transaction was provided by a syndicate led by Madison Capital Partners, Audax Private Debt and Antares Capital.

 

About Long’s Drugs

Headquartered in Columbia, South Carolina, Longs provides comprehensive pharmacy services and distributes specialty pharmaceuticals across the United States. Longs offers tailored pharmacy solutions for Covered Entities, including Ryan White Clinics, Federally Qualified Health Centers, and STD Clinics. Longs owns and operates over 30 pharmacies the Southeast under the Avita and Longs brands.

For more information please visit: www.longsrx.com

For additional information about this transaction, please contact: 
Christian Michalik
Managing Director
(212) 201-6782
[email protected]
 
Matt Bubis
Managing Director
(212) 201-6788
[email protected]


About Kinderhook Industries

Founded in 2003, Kinderhook Industries, LLC is a private investment firm that has raised $8.5 billion of committed capital. We have made in excess of 500 investments and follow-on acquisitions since inception. Kinderhook’s investment philosophy is predicated on matching differentiated, growth-oriented investment opportunities with financial expertise and our proprietary network of operating partners. Our focus is on middle market businesses with defensible niche market positioning in the healthcare services, environmental & industrial services, and light manufacturing & automotive sectors.

For more information, please visit https://www.kinderhook.com


About Avita

Avita Care Solutions is committed to promoting health equities by providing comprehensive, compassionate, and inclusive health care and pharmacy services to underserved communities. Avita’s community care management strategy enables patients and covered entities to remove barriers across the care continuum by providing pharmacy services, program administration, digital health, and delivery of clinical care for more than 145,000 patients and 320+ covered entities at 65+ locations.

For more information, please visit https://AvitaCareSolutions.com/

Copyright © 2025 Kinderhook Industries. All rights reserved.